Melatonin API Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

The global Melatonin API Market has witnessed remarkable growth, reaching a market valuation of US$ 2.9 billion in 2024. The market is projected to continue its rapid expansion, reaching US$ 9 billion by the end of 2031, according to a recent study conducted by Fairfield Market Research.

Key Market Insights:

Melatonin and Its Functions: Melatonin is a widely distributed molecule in living organisms, playing crucial roles in various biological, hormonal, and physiological processes. It is commonly found in medicinal and food plants, particularly in certain seeds. Melatonin is popularly used as an over-the-counter sleep aid due to its role in regulating sleep, alleviating jet lag, and balancing circadian rhythms.

Applications in Cancer Treatment: Melatonin has demonstrated anti-cancer properties against various types of cancer, making it an essential component in cancer treatment. It utilizes both receptor-dependent and receptor-independent mechanisms to combat cancer cells.

Growth Factors: The Melatonin API market is driven by its increasing applications, particularly in cancer treatment, and the integration of automated technologies for API production. Continuous and flexible manufacturing techniques are adopted to meet the growing demand for melatonin APIs and supplements.

Challenges Faced by Melatonin API Providers:

High Raw Material Costs: The production of melatonin APIs involves the chemical conversion of raw materials into refined chemical outputs. This process requires large-scale manufacturing facilities with significant investments in infrastructure, equipment, and quality control.

Why the United States Is a Prominent Market:

The FDA in the United States has established stringent criteria for API manufacturing based on processes, sources, and quality standards. These regulations ensure that melatonin APIs meet high-quality and safety standards, contributing to the market's prominence.

Lucrative Opportunities in Germany:

Germany's market for melatonin APIs benefits from prescription-only availability, leading to higher-quality pharmaceutical melatonin. This has resulted in the need for higher doses of melatonin from pharmaceutical production due to limited bioavailability.

China's Emergence as a Prominent Market:

China's Ministry of Health submits new drug registration clearances to the Chinese Food & Drug Administration (CFDA). Foreign companies seeking to manufacture or import medicines in China must register their imported drug applications, including excipients, packaging components, and APIs produced overseas, resulting in the emergence of China as a prominent market for melatonin APIs.

Competitive Landscape:

The melatonin API market has been driven by low-cost innovations, production efficiency, skilled labor, and innovative research and development activities. Key players in the market include Merck KGaA, Caesar & Loretz GmbH, EVONIK, Bio-Techne Corp., Cayman Chemical Company (Matreya), Spectrum Chemical, LGM Pharma, Flavine Europe GmbH, Ralington Pharma, SimSon Pharma Limited, Santa Cruz Biotechnology, Inc., Biosynth, Otto Chemie Pvt. Ltd., Pharmaffiliates Analytics and Synthetics P. Ltd., and Clearsynth Labs.

Market Segmentation

Source:

Natural
Synthetic
Bio-Synthetic

Grade:

GMP
Non-GMP

Application:

Clinical
Research

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

1. Executive Summary

1.1. Global Melatonin API Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Melatonin API Market Outlook, 2018 - 2031

3.1. Global Melatonin API Market Outlook, by Grade, Value (US$ Bn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. GMP Grade
  - 3.1.1.2. Non-GMP Grade
3.2. Global Melatonin API Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Natural
  - 3.2.1.2. Synthetic
  - 3.2.1.3. Bio-Synthetic
3.3. Global Melatonin API Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Clinical Use
  - 3.3.1.2. Research Use
3.4. Global Melatonin API Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. North America
  - 3.4.1.2. Europe
  - 3.4.1.3. Asia Pacific
  - 3.4.1.4. Latin America
  - 3.4.1.5. Middle East & Africa

4. North America Melatonin API Market Outlook, 2018 - 2031

4.1. North America Melatonin API Market Outlook, by Grade, Value (US$ Bn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. GMP Grade
  - 4.1.1.2. Non-GMP Grade
4.2. North America Melatonin API Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Natural
  - 4.2.1.2. Synthetic
  - 4.2.1.3. Bio-Synthetic
4.3. North America Melatonin API Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Clinical Use
  - 4.3.1.2. Research Use
- 4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Melatonin API Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. U.S. Melatonin API Market by Grade, Value (US$ Bn), 2018 - 2031
  - 4.4.1.2. U.S. Melatonin API Market by Source, Value (US$ Bn), 2018 - 2031
  - 4.4.1.3. U.S. Melatonin API Market by Application, Value (US$ Bn), 2018 - 2031
  - 4.4.1.4. Canada Melatonin API Market by Grade, Value (US$ Bn), 2018 - 2031
  - 4.4.1.5. Canada Melatonin API Market by Source, Value (US$ Bn), 2018 - 2031
  - 4.4.1.6. Canada Melatonin API Market by Application, Value (US$ Bn), 2018 - 2031
- 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Melatonin API Market Outlook, 2018 - 2031

5.1. Europe Melatonin API Market Outlook, by Grade, Value (US$ Bn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. GMP Grade
  - 5.1.1.2. Non-GMP Grade
5.2. Europe Melatonin API Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Natural
  - 5.2.1.2. Synthetic
  - 5.2.1.3. Bio-Synthetic
5.3. Europe Melatonin API Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Clinical Use
  - 5.3.1.2. Research Use
- 5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Melatonin API Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Germany Melatonin API Market by Grade, Value (US$ Bn), 2018 - 2031
  - 5.4.1.2. Germany Melatonin API Market by Source, Value (US$ Bn), 2018 - 2031
  - 5.4.1.3. Germany Melatonin API Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.4. U.K. Melatonin API Market by Grade, Value (US$ Bn), 2018 - 2031
  - 5.4.1.5. U.K. Melatonin API Market by Source, Value (US$ Bn), 2018 - 2031
  - 5.4.1.6. U.K. Melatonin API Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.7. France Melatonin API Market by Grade, Value (US$ Bn), 2018 - 2031
  - 5.4.1.8. France Melatonin API Market by Source, Value (US$ Bn), 2018 - 2031
  - 5.4.1.9. France Melatonin API Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.10. Italy Melatonin API Market by Grade, Value (US$ Bn), 2018 - 2031
  - 5.4.1.11. Italy Melatonin API Market by Source, Value (US$ Bn), 2018 - 2031
  - 5.4.1.12. Italy Melatonin API Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.13. Turkey Melatonin API Market by Grade, Value (US$ Bn), 2018 - 2031
  - 5.4.1.14. Turkey Melatonin API Market by Source, Value (US$ Bn), 2018 - 2031
  - 5.4.1.15. Turkey Melatonin API Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.16. Russia Melatonin API Market by Grade, Value (US$ Bn), 2018 - 2031
  - 5.4.1.17. Russia Melatonin API Market by Source, Value (US$ Bn), 2018 - 2031
  - 5.4.1.18. Russia Melatonin API Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.19. Rest of Europe Melatonin API Market by Grade, Value (US$ Bn), 2018 - 2031
  - 5.4.1.20. Rest of Europe Melatonin API Market by Source, Value (US$ Bn), 2018 - 2031
  - 5.4.1.21. Rest of Europe Melatonin API Market by Application, Value (US$ Bn), 2018 - 2031
- 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Melatonin API Market Outlook, 2018 - 2031

6.1. Asia Pacific Melatonin API Market Outlook, by Grade, Value (US$ Bn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. GMP Grade
  - 6.1.1.2. Non-GMP Grade
6.2. Asia Pacific Melatonin API Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Natural
  - 6.2.1.2. Synthetic
  - 6.2.1.3. Bio-Synthetic
6.3. Asia Pacific Melatonin API Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Clinical Use
  - 6.3.1.2. Research Use
- 6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Melatonin API Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. China Melatonin API Market by Grade, Value (US$ Bn), 2018 - 2031
  - 6.4.1.2. China Melatonin API Market by Source, Value (US$ Bn), 2018 - 2031
  - 6.4.1.3. China Melatonin API Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.4. Japan Melatonin API Market by Grade, Value (US$ Bn), 2018 - 2031
  - 6.4.1.5. Japan Melatonin API Market by Source, Value (US$ Bn), 2018 - 2031
  - 6.4.1.6. Japan Melatonin API Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.7. South Korea Melatonin API Market by Grade, Value (US$ Bn), 2018 - 2031
  - 6.4.1.8. South Korea Melatonin API Market by Source, Value (US$ Bn), 2018 - 2031
  - 6.4.1.9. South Korea Melatonin API Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.10. India Melatonin API Market by Grade, Value (US$ Bn), 2018 - 2031
  - 6.4.1.11. India Melatonin API Market by Source, Value (US$ Bn), 2018 - 2031
  - 6.4.1.12. India Melatonin API Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.13. Southeast Asia Melatonin API Market by Grade, Value (US$ Bn), 2018 - 2031
  - 6.4.1.14. Southeast Asia Melatonin API Market by Source, Value (US$ Bn), 2018 - 2031
  - 6.4.1.15. Southeast Asia Melatonin API Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.16. Rest of Asia Pacific Melatonin API Market by Grade, Value (US$ Bn), 2018 - 2031
  - 6.4.1.17. Rest of Asia Pacific Melatonin API Market by Source, Value (US$ Bn), 2018 - 2031
  - 6.4.1.18. Rest of Asia Pacific Melatonin API Market by Application, Value (US$ Bn), 2018 - 2031
- 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Melatonin API Market Outlook, 2018 - 2031

7.1. Latin America Melatonin API Market Outlook, by Grade, Value (US$ Bn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. GMP Grade
  - 7.1.1.2. Non-GMP Grade
7.2. Latin America Melatonin API Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
7.3. Latin America Melatonin API Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Clinical Use
  - 7.3.1.2. Research Use
- 7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Melatonin API Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Brazil Melatonin API Market by Grade, Value (US$ Bn), 2018 - 2031
  - 7.4.1.2. Brazil Melatonin API Market by Source, Value (US$ Bn), 2018 - 2031
  - 7.4.1.3. Brazil Melatonin API Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.4.1.4. Mexico Melatonin API Market by Grade, Value (US$ Bn), 2018 - 2031
  - 7.4.1.5. Mexico Melatonin API Market by Source, Value (US$ Bn), 2018 - 2031
  - 7.4.1.6. Mexico Melatonin API Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.4.1.7. Argentina Melatonin API Market by Grade, Value (US$ Bn), 2018 - 2031
  - 7.4.1.8. Argentina Melatonin API Market by Source, Value (US$ Bn), 2018 - 2031
  - 7.4.1.9. Argentina Melatonin API Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.4.1.10. Rest of Latin America Melatonin API Market by Grade, Value (US$ Bn), 2018 - 2031
  - 7.4.1.11. Rest of Latin America Melatonin API Market by Source, Value (US$ Bn), 2018 - 2031
  - 7.4.1.12. Rest of Latin America Melatonin API Market by Application, Value (US$ Bn), 2018 - 2031
- 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Melatonin API Market Outlook, 2018 - 2031

8.1. Middle East & Africa Melatonin API Market Outlook, by Grade, Value (US$ Bn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. GMP Grade
  - 8.1.1.2. Non-GMP Grade
8.2. Middle East & Africa Melatonin API Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Natural
  - 8.2.1.2. Synthetic
  - 8.2.1.3. Bio-Synthetic
8.3. Middle East & Africa Melatonin API Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Clinical Use
  - 8.3.1.2. Research Use
- 8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Melatonin API Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. GCC Melatonin API Market by Grade, Value (US$ Bn), 2018 - 2031
  - 8.4.1.2. GCC Melatonin API Market by Source, Value (US$ Bn), 2018 - 2031
  - 8.4.1.3. GCC Melatonin API Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.4. South Africa Melatonin API Market by Grade, Value (US$ Bn), 2018 - 2031
  - 8.4.1.5. South Africa Melatonin API Market by Source, Value (US$ Bn), 2018 - 2031
  - 8.4.1.6. South Africa Melatonin API Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.7. Egypt Melatonin API Market by Grade, Value (US$ Bn), 2018 - 2031
  - 8.4.1.8. Egypt Melatonin API Market by Source, Value (US$ Bn), 2018 - 2031
  - 8.4.1.9. Egypt Melatonin API Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.10. Nigeria Melatonin API Market by Grade, Value (US$ Bn), 2018 - 2031
  - 8.4.1.11. Nigeria Melatonin API Market by Source, Value (US$ Bn), 2018 - 2031
  - 8.4.1.12. Nigeria Melatonin API Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.13. Rest of Middle East & Africa Melatonin API Market by Grade, Value (US$ Bn), 2018 - 2031
  - 8.4.1.14. Rest of Middle East & Africa Melatonin API Market by Source, Value (US$ Bn), 2018 - 2031
  - 8.4.1.15. Rest of Middle East & Africa Melatonin API Market by Application, Value (US$ Bn), 2018 - 2031
- 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. By End User vs by Source Heat map
9.2. Manufacturer vs by Source Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
- 9.5.1. Merck
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Product Portfolio
  - 9.5.1.3. Financial Overview
  - 9.5.1.4. Business Strategies and Development
- 9.5.2. Caesar & Loretz GmbH
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Product Portfolio
  - 9.5.2.3. Financial Overview
  - 9.5.2.4. Business Strategies and Development
- 9.5.3. EVONIK
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Product Portfolio
  - 9.5.3.3. Financial Overview
  - 9.5.3.4. Business Strategies and Development
- 9.5.4. Cayman Chemical Company (Matreya)
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Product Portfolio
  - 9.5.4.3. Financial Overview
  - 9.5.4.4. Business Strategies and Development
- 9.5.5. Bio-Techne Corp.
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Product Portfolio
  - 9.5.5.3. Financial Overview
  - 9.5.5.4. Business Strategies and Development
- 9.5.6. LGM Pharma
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Product Portfolio
  - 9.5.6.3. Financial Overview
  - 9.5.6.4. Business Strategies and Development
- 9.5.7. Flavine Europe GmbH
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Product Portfolio
  - 9.5.7.3. Financial Overview
  - 9.5.7.4. Business Strategies and Development
- 9.5.8. Ralington Pharma
  - 9.5.8.1. Company Overview
  - 9.5.8.2. Product Portfolio
  - 9.5.8.3. Financial Overview
  - 9.5.8.4. Business Strategies and Development
- 9.5.9. SimSon Pharma Limited
  - 9.5.9.1. Company Overview
  - 9.5.9.2. Product Portfolio
  - 9.5.9.3. Financial Overview
  - 9.5.9.4. Business Strategies and Development
- 9.5.10. Biosynth
  - 9.5.10.1. Company Overview
  - 9.5.10.2. Product Portfolio
  - 9.5.10.3. Financial Overview
  - 9.5.10.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations